Monday, June 22, 2015

Debate is flaring up over whether pharmacists should be able to switch patients to biosimilar medicines. As part of its PBS reform package,

Substitution stoush

Pharmacy News-18 hours ago
Debate is flaring up over whether pharmacists should be able to switch patients to biosimilar medicines. As part of its PBS reform package, currently before the ...
A call for clarity in policy around drugs known as “biosimilars”
Crikey (registration) (blog)-18 hours ago
Explore in depth  (3 more articles)

FDA 2015 Pharmacy Inspections and Related Records as of June 19, 2015

FDA 483 Merissa Corp. dba Johnson Compounding and Wellness, Waltham, MA. Issued 05/28/2015

FDA 483 Central Illinois Compounding, Inc. dba Preckshot Professional Pharmacy, Peoria Heights, IL. Issued 05/14/2015 (PDF - 910KB)

Regulatory Recon: Will FDA Have Enough Money to Hire the Staff it .

Regulatory Recon: Will FDA Have Enough Money to Hire the Staff it ...

Regulatory Focus-7 hours ago
Regulatory Recon: Will FDA Have Enough Money to Hire the Staff it Needs? ... Inc. Receives FDA Fast Track Designation for Lead Compound Encenicline to ...